Skip to main content

Full Schedule

Full Schedule

  • Wednesday, November 9, 2022
  • 9:00 AM – 10:45 AM
    Session I: EGFR

    Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Lyudmila Bazhenova, MD – University of California, San Diego

    Presenter: Jamie E. Chaft, MD – Memorial Sloan Kettering Cancer Center

    Presenter: Jonathan Goldman, MD – UCLA

    Presenter: Joel W. Neal, MD, PhD – Stanford University Medical Center

  • 10:45 AM – 10:55 AM
    Exhibit Hall
  • 10:55 AM – 11:55 AM
    EXKIVITY® (mobocertinib) The first and only oral therapy designed to target EGFR Exon20 insertion+ mNSCLC
  • 11:55 AM – 12:05 PM
    Exhibit Hall
  • 12:05 PM – 1:15 PM
    Session II: Rearrangements: ROS1 and ALK

    Moderator: Edward B. Garon, MD, MS – University of California, Los Angeles

    Presenter: Jessica J. Lin, MD – Harvard Medical School

    Presenter: Rajwanth Veluswamy, MD, MSCR – Icahn School of Medicine at Mount Sinai

  • 1:15 PM – 1:35 PM
    Exhibit Hall
  • 1:35 PM – 1:40 PM
    Session III: Other Actionable Biomarkers
  • 1:35 PM – 2:35 PM
    Session III: Other Actionable Biomarkers
  • 1:35 PM – 2:50 PM
    Session III: Other Actionable Biomarkers

    Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Lyudmila Bazhenova, MD – University of California, San Diego

    Presenter: Jonathan Goldman, MD – UCLA